GTS FINANCIAL, LLC
CIK
2112647
Location
BLOOMINGTON, MN
Portfolio Value
Micro
$1,471,027
Diversification
Highly concentrated
Filing Date
Mar 31, 2026
Global Rank
#8,134
/ 8,232
Top Industry
Drug Manufacturers - General
65.3%
Period ended 2 months ago
Filed May 19, 2026 · 26d
Clone Performance
May 2026–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+9.0%
SPY
+0.2%
Annualised alpha
—
Max drawdown
−4.2%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
2 positions · as of Mar 31, 2026Top Position
65.3%
of portfolio value
Top 5
100.0%
of portfolio value
Top 10
100.0%
of portfolio value
HHI
5,471
Highly concentrated
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 65.3% | $961,159 |
| Financial Services | 34.7% | $509,868 |
2 positions ·
$1,471,027 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| LLY |
ELI LILLY & Co
Healthcare
|
First | 1,045 | $961,159 | 65.34% | |
| BRK-B |
Berkshire Hathaway Inc
Financial Services
|
First | 1,064 | $509,868 | 34.66% |